Ophthalmic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Eye Improvements in Neovascular AMD Patients ...

Topical dorzolamide hydrochloride-timolol appears to reduce central subfield thickness and subretinal fluid in eyes of patients with neovascular age-related macular degeneration (AMD) and incomplete response to anti-vascular endothelial growth factor (VEGF) therapy.

Carotenoids in Fruits, Vegetables and AMD

A greater intake of bioavailable carotenoids, particularly lutein/zeaxanthin and beta-carotene, has been linked to a reduced risk of advanced age-related macular degeneration (AMD) based on two prospective cohort studies.

Dry Eyes: Updates on Diagnosis, Treatment

As dry eyes is one of the most common reasons for patient visits to eye care professionals, the latest issue of the journal Optometry and Vision Science focuses on progress in the risk factors, diagnosis, and treatment of dry eye disease.

USPSTF Revisits Eye Screening for Seniors

The USPSTF has concluded that there is currently insufficient evidence to assess the benefits and harms of screening for impaired visual acuity in older adults.

Smart' intelli-Case Cleared by FDA

The FDA has cleared the intelli-Case for use with hydrogen peroxide solutions.

Eye Bacteria Changes With Contact Lenses

Changes in bacteria populations may be one reason why people who wear contact lenses are more prone to eye infections, a new study suggests.

Ophthalmic NSAIDs for Common Indications Compared

A recent review compared published data on the efficacy of several ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs), within and outside their FDA-approved uses.

News

Efficacy of FS Laser Capsulotomy May Decrease in Mature Cataracts

Femtosecond (FS) laser capsulotomy efficacy is decreased in mature cataracts, with higher occurrence rates of tags, according to a study published online in Lasers in Surgery and Medicine.

Study Suggests These Drugs Are Best for Reducing IOP in Glaucoma

Highest-ranking class for reducing intraocular pressure was prostaglandins for 1999, 2004, 2009

BromSite Approved for Ocular Inflammation, Pain in Cataract Surgery

The Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for BromSite (bromfenac ophthalmic solution; InSite Vision) for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.

Clinical Charts

Make prescribing decisions with our charts and treatment algorithms.

Featured courses from mycme

Lucentis Found Effective for Diabetic RetinopathyExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Disappointing Results Seen Thus Far for Choosing WiselyExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Cannabinoid Offers Modest Relief From Pain, SpasticityExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters